Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
Parker Conrad, CEO and co-founder of once high-flying Zenefits, has resigned amid a scandal involving allegations that employees sold insurance without holding proper licenses to do so.
Embattled drug entrepreneur Martin Shkreli — who vigorously defended his decision to hike the price of a life-saving drug from $13.50 to $750 — suddenly went silent Thursday at a Congressional committee, smirking and grinning instead of answering questions.
Stung by losses under the federal health law, major insurers are seeking to sharply limit how policies are sold to individuals in ways that consumer advocates say seem to discriminate against the sickest and could hold down future enrollment.
President Barack Obama will propose tailoring the controversial "Cadillac tax" on expensive private health insurance plans to reflect regional differences when he releases his 2017 budget plan next week, a senior White House adviser said in an article released on Wednesday.
A new hospital model is coming to the Las Vegas Valley. Dignity Health, which runs three St. Rose Dominican campuses in Henderson and southwest Las Vegas, plans four smaller neighborhood hospitals across the Las Vegas Valley in the next two years.
In response to recent infections and deaths from tainted medical scopes, U.S. lawmakers are wrestling with how to keep other dangerous devices from harming patients.
After Martin Shkreli raised the price of anti-parasitic drug Daraprim more than 50-foldto $750 a pill last year, he said he wasn’t alone in taking big price hikes. As it turns out, the former drug executive was right. A survey of about 3,000 brand-name prescription drugs found that prices more than doubled for 60 and at least quadrupled for 20 since December 2014.
Open enrollment for 2016 ends Sunday for those who buy health plans from the private market or health insurance exchanges. But if you don’t act by the deadline, are you completely out of luck?
The Internal Revenue Service is warning consumers about tax scams involving the Affordable Care Act and penalties imposed under the law on people who go without health insurance.
Undercutting rivals on price is an unusual and stealthily brilliant strategy from Merck. It will likely burnish the company's image at a time when politicians are aggressively attacking high drug prices. It could possibly reshape the way drugs are priced. And who doesn't like a good old-fashioned price war?